“…Their study adds new data, as they focused on severe ARDS patients presenting cerebral dysfunction during ICU stay, mostly acute encephalopathy (80%). In comparison with our study published in the journal that reported 4-month follow-up of severe COVID-19–associated ARDS survivors, their findings suggest an improved functional outcome at 1 year (modified Rankin Scale ≤ 2: 28% vs 61% at 4 mo) but a similar rate of persistent cognitive impairment (Montreal Cognitive Assessment < 26, 57% at 1 yr vs 52% at 4 mo) (1, 2).…”